Characterization of the molecular events following impairment of NF-κB-driven transcription in neurons

Molecular Brain Research

Volumn 109, Issue 1-2, 2002, Pages 179-188

  Chiarugi, Alberto ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

A1; Akt; Apoptosis; Bcl 2; Bcl xL; Cytochrome c; NF B

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; ENZYME PRECURSOR; HELENALIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARTHENOLIDE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; SN 50; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSCRIPTION; MITOCHONDRION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELLS, CULTURED; CEREBRAL CORTEX; CYTOCHROME C GROUP; DNA; DNA-BINDING PROTEINS; HOMEOSTASIS; MITOCHONDRIA; NEURONS; NF-KAPPA B; NITRILES; ORGANIC CHEMICALS; PEPTIDES; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REPLICATION PROTEIN C; SESQUITERPENES; SULFONES; TRANSCRIPTION, GENETIC;

EID: 0037203299     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00558-2     Document Type: Article

References (58)

1. Bentires-Aji M., Dejardin E., Viatour P., Van Lint C., Froesch B., Reed J.C., Merville M.P., Bours V. Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell. Oncogene. 20:2001;2805-2813.
2. Boothby M. Specificity of SN50 for NF-κB? Nat. Immunol. 2:2001;471-472.
3. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:2001;657-664.
4. Brivanolu A.H., Darnell J.E.J. Signal transduction and the control of gene expression. Science. 295:2002;813-818.
5. Collins T.J., Berridge M.J., Lipp P., Bootman M.D. Mitochondria are morphologically and functionally heterogeneous within cells. EMBO J. 21:2002;1616-1627.
6. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., Memo M. Activation of cell-cycle associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 24:2001;25-31.
7. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
8. Deveraux Q.L., Reed J.C. IAP family proteins: suppressor of apoptosis. Genes Dev. 13:1999;239-252.
9. Dijkers P.F., Birkenkamp K.U., Lam E.W.F., Thomas S.B., Lammers J.W.J., Koenderman L., Coffer P.J. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J. Cell Biol. 156:2002;531-542.
10. Gentry J.J., Casaccia-Bonnefil P., Carter B.D. Nerve growth factor activation of nuclear factor-kB through its p75 receptor is an anti-apoptotic signal in RN22 schwannoma cells. J. Biol. Chem. 275:2000;7558-7656.
11. Grilli M., Memo M. Possible role of NF-kB and p53 in the glutamate-induced proapoptotic neuronal pathway. Cell Death Diff. 6:1999;22-27.
12. Grilli M., Pizzi M., Memo M., Spano P.F. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation. Science. 274:1996;1383-1385.
13. Gross A., McDonnell J.M., Korsmeyer S.J. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
14. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
15. Hehner S.P., Heinrich M., Bork P.M., Vogt M., ratter F., Lehmann V., Schulze-Osthoff K., Droge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-kB by preventing the degradation of IkBα and IkBβ J. Biol. Chem. 273:1998;1288-1297.
16. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Stimulation of ionotropic glutamate receptors activate transcription factor kB in primary neurons. Proc. Natl. Acad. Sci. 92:1995;9618-9622.
17. Karin M. How NF-kB is activated: the role of the IkB kinase (IKK) complex. Oncogene. 18:1999;6867-6874.
18. Karin M., Lin A. NF-kB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227.
19. Kasibhatla S., Genesteir L., Green D.R. Regulation of fas ligand expression during activation induced cell death in T lymphocytes via nuclear factor κB. J. Biol. Chem. 274:1999;987-992.
20. Levkau B., Scatena M., Giachelli C.M., Ross R., Raines E.W. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kB loop. Nat. Cell Biol. 1:1999;227-233.
21. Li X., Stark G.R. NFkB-dependent signaling pathways. Exp. Hematol. 30:2002;285-296.
22. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
23. Lin Y.Z., Yao S., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NFkB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequences. J. Biol. Chem. 270:1995;14255-14258.
24. Lipton S.A. Janus faces of NFkB activity: neurodestruction versus neuroprotection. Nat. Med. 3:1997;20-22.
25. Liss G., Knorre A., Schmidt T.J., Pahl H.L., Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kB by directly targeting p65. J. Biol. Chem. 273:1998;33508-33516.
26. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis. J. Neurosci. Methods. 96:2000;147-152.
27. MacManus J.P., Linnik M.D. Gene expression induced by cerebral ischemia: an apoptotic perspective. J. Cereb. Blood Flow Metab. 17:1997;815-832.
28. Maggirwar S.B., Sarmiere P.D., Dewhurst S., Freeman R.S. Nerve growth factor-dependent activation of NF-kB contributes to survival of sympathetic neurons. J. Neurosci. 18:1998;10356-10365.
29. Marshansky V., Wang X., Ertrand R., Luo H., Duguid W., Chinnadurai G., Kanaan N., Diem Vu M., Jangping W. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J. Immunol. 166:2001;3130-3142.
30. Martinou J.C., Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2:2001;63-67.
31. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1:2000;120-129.
32. Mattson M.P., Camandola S. NF-kB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107:2001;247-254.
33. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of nuclear factor κB in neuronal survival and plasticity. J. Neurochem. 74:2000;443-456.
34. Middleton G., Hamanoue M., Enokido Y., Wyatt S., Pennica D., Jaffray E., Hay R.T., Davies A.M. Cytokine-induced nuclear factor κ B activation promotes the survival of developing neurons. J. Cell Biol. 148:2000;325-332.
35. Moulding D.A., Akgul C., Derouet M., Withe M.R.H., Edwards S.W. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J. Leukoc. Biol. 70:2001;783-792.
36. Neame S.J., Rubin L.L., Philpott K.L. Blocking cytochrome c activity within intact neurons inhibits apoptosis. J. Cell Biol. 142:1998;1583-1593.
37. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3:2002;216-227.
38. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature. 407:2000;810-816.
39. Nijhawan D., Honarpour N., Wang X. Apoptosis in neuronal development and disease. Annu. Rev. Neurosci. 23:2000;73-87.
40. Nozaki S., Sledge G.W., Nakshatri H. Repression of GADD153/CHOP by NF-kB: a possible cellular defense against endoplasmic reticulum stress-induced cell death. Oncogene. 20:2001;2178-2185.
41. Pagliari L.J., Parlman H., Liu H., Pope R.M. Macrophages require constitutive NF-kB activation to maintain A1 expression and mitochondrial homeostasis. Mol. Cell Biol. 20:2000;8855-8865.
42. Perkins N.D. The Rel/NF-kB family: friend and foe. Trends Biochem. Sci. 25:2000;434-440.
43. Pierce J.W., Scholenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerristen M.E. Novel inhibitors of cytokine-induced IkB α phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272:1997;21096-21103.
44. Putcha G.V., Deshmukh M., Johnson E.M. Jr. Inhibition of apoptotic signaling cascade causes loss of trophic factor dependence during neuronal maturation. J. Cell Biol. 149:2000;1011-1017.
45. Qin Z.H., Wang Y., Nakai M., Chase T.N. Nuclear factor-kB contributes to excitotoxin induced apoptosis in rat striatum. Mol. Pharmacol. 53:1998;33-42.
46. Reed J.C. A day in the life of the Bcl-2 protein: does the turnover rate of Bcl-2 serve as a biological clock for cellular lifespan regulation? Leukemia Res. 20:1996;109-111.
47. Reichert S.A., Kim-Han J.S., Dugan L.L. The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocyte during oxygen-glucose deprivation. J. Neurosci. 21:2001;6608-6616.
48. 2+ responses. Science. 280:1998;1763-1766.
49. Scheneider A., Martin-Villalba A., Wehi F., Vogel J., Wirth T., Schwaninger M. NF-kB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:1999;554-559.
50. Schmitz M.L., Bacher S., Kracht M. IkB-independent control of NF-kB activity by modulatory phosphorylation. Trends Biochem. Sci. 26:2001;186-190.
51. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the Cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:1999;281-292.
52. Sobota R., Szwed M., Kasza A., Bugno M., Kordula T. Parthenolide inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokine of the IL-6 family. Biochem. Biophys. Res. Commun. 267:2000;329-333.
53. Taglialatela G., Robinson R., Perez-Polo J.R. Inhibition of nuclear factor-kB activity induces nerve growth factor-resistant apoptosis. J. Neurosci. Res. 47:1997;155-162.
54. Tamatani M., Mitsuda N., Matsuzaki H., Okado H., Miyake S., ViteK M.P., Yamaguchi A., Tohyama M. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: Roles of nuclear factor-kB and Bcl-2. J. Neurochem. 75:2000;683-693.
55. Wang L., Chen R.X., Kallenbach N.R. Proteolysis as a probe of thermal unfolding of cytochrome c. Proteins. 30:1998;435-441.
56. Wang J.M., Chao J.R., Chen W., Kuo M.L., Yen Y.Y., Yang-Yen H.F. The antiapoptotic gene mcl-1 is upregulated by the phosphatidyinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol. Cell Biol. 19:1999;6195-6206.
57. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.W., Baldwin A.S. Jr. NF-kB antiapoptosis: induction of TRAF1 and TRAF2 and cIAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
58. Zamzami N., Kroemer G. The mitochondrion in apoptosis, how the pandora box opens. Nat. Rev. Mol. Cell Biol. 2:2001;67-71.